Plain-English translation of NCT07276711 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the EmStop Embolic Protection System, a device designed to catch small pieces of material that might break loose during a minimally invasive aortic valve replacement procedure. Researchers want to see if this new device works better than an older device called the Sentinel device at protecting your brain and other organs during the procedure. You would receive one of these two devices during your valve replacement surgery.
During aortic valve replacement surgery, small pieces of material can sometimes break free and travel through your bloodstream, potentially causing stroke or other complications. This trial exists to find out whether the new treatment can better protect patients from these risks compared to devices currently being used.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you would be randomly assigned to receive either the EmStop device or the Sentinel device during your scheduled aortic valve replacement procedure. The procedure itself is minimally invasive, meaning it uses small incisions rather than open-heart surgery. After the procedure, you would be followed closely for 30 days with specialized neurological assessments to monitor for any complications. Researchers will track how well each device protects you during and after the surgery.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States